APT Medical Inc.

Shanghai Stock Exchange 688617.SS

APT Medical Inc. Price to Earnings Ratio (P/E) on January 14, 2025: 62.14

APT Medical Inc. Price to Earnings Ratio (P/E) is 62.14 on January 14, 2025, a 36.89% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

APT Medical Inc. 52-week high Price to Earnings Ratio (P/E) is 80.20 on October 08, 2024, which is 29.06% above the current Price to Earnings Ratio (P/E).
APT Medical Inc. 52-week low Price to Earnings Ratio (P/E) is 38.50 on July 30, 2024, which is -38.05% below the current Price to Earnings Ratio (P/E).
APT Medical Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is 57.92.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Shanghai Stock Exchange: 688617.SS

APT Medical Inc.

CEO	Mr. Zhenghui Cheng
IPO Date	Jan. 7, 2021
Location	China
Headquarters	601, Building B
Employees	2,155
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

APT Medical Inc. engages in the research and development, manufacture, and sale of invasive interventional medical devices for cardiovascular and cerebrovascular diseases worldwide. The company offers electrophysiological catheter delivery systems, as well as radiofrequency ablation and mapping catheters; and vascular intervention products, such as diagnostic and treatment products, and intervention accessories. It also provides OEM/ODM services to catheter and metal products, as well as accessories. The company was founded in 2002 and is headquartered in Shenzhen, China.

Key trends

Past 5 years